SEC Form 4 · accession 0000914190-17-000026
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert M. Gavin
Officer — Senior V.P. Protein Platforms
Period of report
Feb 1, 2017
Accepted (ET)
Feb 3, 2017 · 6:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 1, 2017 | M | 1,667 | $0.00 | A | 1,667 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $93.32 | Feb 1, 2017 | D | 33,333 | D | — | Jul 31, 2021 | Common Stock | 33,333 | 16,667 | D |
| Restricted Stock UnitsF6,F4 | — | Feb 1, 2017 | M | 1,667 | D | — | — | Common Stock | 1,667 | 0 | D |
| Stock Option (Right to Buy)F8 | $106.59 | Aug 18, 2016 | A | 17,371 | A | — | Aug 18, 2023 | Common Stock | 17,371 | 17,371 | D |
| Stock Option (Right to Buy)F9 | $106.59 | Aug 18, 2016 | A | 13,028 | A | — | Aug 18, 2023 | Common Stock | 13,028 | 13,028 | D |
| Restricted Stock UnitsF6,F9 | — | Aug 18, 2016 | A | 2,111 | A | — | — | Common Stock | 2,111 | 2,111 | D |
| Stock Option (Right to Buy)F1 | $93.32 | holding | — | — | — | — | Jul 31, 2021 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy)F3 | $90.25 | holding | — | — | — | — | Nov 30, 2021 | Common Stock | 5,000 | 5,000 | D |
| Stock Option (Right to Buy)F5 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 12,500 | 12,500 | D |
| Stock Option (Right to Buy)F7 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 9,375 | 9,375 | D |
| Restricted Stock UnitsF6,F7 | — | holding | — | — | — | — | — | Common Stock | 1,500 | 1,500 | D |
Explanation of responses
- F12,500 shares vest on each of 7/31/15, 7/31/16, 7/31/17 and 7/31/18.
- F2On 2/1/17, the Board of Directors authorized discretionary vesting for 16,667 performance options. The remainder of the performance options were forfeited.
- F31,500 shares vest on each of 12/1/15, 12/1/16, 12/1/17 and 12/1/18.
- F4On 2/1/17, the Board of Directors authorized discretionary vesting for 1,667 performance RSUs. The remainder of the performance RSUs were foreited.
- F53,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
- F6Each restricted stock unit represents a contingent right to receive one shares of Bio-Techne common stock.
- F7Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F8Vests 4,343 shares on each of 8/18/17, 8/18/18 and 8/18/19, and 4,342 shares on 8/18/20.
- F9Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).